S7 E. 1 From Seed to Sale: How Equilibria Found Whitespace in the Competitive $20 Billion CBD Market

It’s safe to say there is a lot of buzz around CBD and it’s easy to see why. Leading cannabis researchers project that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024. Who wouldn’t want a slice of that pie? When Coco Meers launched her CBD company, Equilibria, in the spring of 2018 the space was already flooded with thousands of brands. But instead of being discouraged by the competition, Coco and her co-founder, Marcy Capron Vermillion were driven by it. The duo also didn’t view the current brands as competitors. Most of them were not seed-to-sale or medical-grade and it was clear the market was ripe for transparency and results-driven formulas. They quickly got to work on filling the whitespace. But Equilibria is so much more than just a premium, farm-fresh, full-spectrum CBD product line. The co-founders went one step further by offering personalized medical-grade CBD routines and dedicated one-on-one dosage support with a specialist—they’re the only CBD brand to offer that service. As a “for women, by women” company, they understand that female bodies are different—from cyclical changes to the very real challenges of menopause, childbirth, and everything in-between—and women deserve a CBD brand that can deliver all of the above. In this episode of WorkParty, Jaclyn sits down with Coco to dive Equilibria's seed to sale concept, why we should all believe the hype around CBD, and how they’ve built trust in an unregulated industry. Join the party on social @workparty and stay in-the-know at workparty.com.

www.hellorory.com/PARTY to get Nightly Defense for just $5!

www.usualwines.com with code WORKPARTY for $8 off your first order, and try the first glass FREE!

Produced by Dear Media